Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.
Share on MySpace




Latest Member Blogs

Member
Total Posts: 1
1/24/2012
08:37PM
Member
Total Posts: 2
12/7/2011
09:14AM
Member
Total Posts: 1
11/8/2011
01:37AM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
BofA downgrades Biocon stock rating - Expressindia.com

BofA downgrades Biocon stock rating
Expressindia.com
Bank of America (BofA) has downgraded India's top-listed biotechnology company Kiran Mazumdar-Shah-led Biocon to underperform from neutral and has cut its target price to 260 rupees from 395 rupees citing dismal third-quarter earnings and weak outlook.

Spectrum Pharmaceuticals Strengthens Commercial Operations - EON: Enhanced Online News (press release)

Spectrum Pharmaceuticals Strengthens Commercial Operations
EON: Enhanced Online News (press release)
(EON: Enhanced Online News)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the promotions of Rick ...

and more »
Camagüey to Strengthen its Potential in the Scientific Development - Radio Cadena Agramonet

Radio Cadena Agramonet

Camagüey to Strengthen its Potential in the Scientific Development
Radio Cadena Agramonet
In the months to come, specialists from the Center for Genetic Engineering and Biotechnology (CIGB) will continue their researches on Heberprovac –which is a product developed by this hub and an effective prostate cancer vaccinal candidate.

S&P Indices Announces Change to U.S. Index - SYS-CON Media (press release)

S&P Indices Announces Change to U.S. Index
SYS-CON Media (press release)
Momenta Pharmaceuticals is a biotechnology company specializing in the characterization and process engineering of complex molecules. Headquartered in Cambridge, MA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification ...

and more »
S&P Indices Announces Change to U.S. Index - MarketWatch (press release)

S&P Indices Announces Change to U.S. Index
MarketWatch (press release)
Momenta Pharmaceuticals is a biotechnology company specializing in the characterization and process engineering of complex molecules. Headquartered in Cambridge, MA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification ...

and more »
CEO of personalized cancer treatment testing and dosage firm resigns - MedCity News

MedCity News

CEO of personalized cancer treatment testing and dosage firm resigns
MedCity News
A biotechnology company that develops tests for more personalized cancer treatments has begun looking for a new CEO after the current head of the company submitted his resignation for family reasons. He will be replaced by a senior vice-president from ...

and more »
S&P Indices Announces Change to US Index - MarketWatch (press release)

S&P Indices Announces Change to US Index
MarketWatch (press release)
Momenta Pharmaceuticals is a biotechnology company specializing in the characterization and process engineering of complex molecules. Headquartered in Cambridge, MA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification ...

and more »
Rockville Biotech Micromet Sold for $1.16B - Patch.com

Rockville Biotech Micromet Sold for $1.16B
Patch.com
The acquisition gives Amgen, the world's largest biotechnology company, ownership of blinatumomab, which is in clinical development for use against two blood cancers: acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Micromet was not expected to ...

and more »
CURCA Funds Students' Research in Pharmacology and Toxicology - UB School of Medicine and Biomedical Sciences News

CURCA Funds Students' Research in Pharmacology and Toxicology
UB School of Medicine and Biomedical Sciences News
Bansi Vedia, a senior majoring in biotechnology, is analyzing the effect drugs have on human oligodendrocyte progenitor differentiation and proliferation. She works with Fraser J. Sim, PhD, whose lab seeks to understand how human neural stem and ...

Museum of Science gets $5M grant - Boston Business Journal

Museum of Science gets $5M grant
Boston Business Journal
The Massachusetts Life Sciences Center gave a $5 million grant to the Museum of Science Boston on Wednesday to build an exhibit on biology and biotechnology to be called the Hall of Human Life (HHL). The exhibit, expected to open next summer, ...

and more »